BioNTech Past Earnings Performance

Past criteria checks 0/6

BioNTech has been growing earnings at an average annual rate of 22.7%, while the Biotechs industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 26.3% per year.

Key information

22.7%

Earnings growth rate

22.9%

EPS growth rate

Biotechs Industry Growth-14.6%
Revenue growth rate26.3%
Return on equity-2.6%
Net Margin-18.7%
Next Earnings Update04 Nov 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How BioNTech makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XTRA:22UA Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 242,691-5046122,168
31 Mar 242,7301135661,957
31 Dec 233,8199305581,783
30 Sep 236,6182,7515551,715
30 Jun 239,1844,3755501,559
31 Mar 2312,2136,2385601,585
31 Dec 2217,3119,4345411,537
30 Sep 2218,56510,3225561,299
30 Jun 2221,19111,7484801,217
31 Mar 2223,30312,8633941,019
31 Dec 2118,97710,293327949
30 Sep 2113,7907,493229935
30 Jun 217,7704,072178902
31 Mar 212,5031,197139796
31 Dec 2048215109645
30 Sep 20165-41079453
30 Jun 20126-23063275
31 Mar 20110-19257232
31 Dec 19109-17949227
30 Sep 19144-12253208
30 Jun 19136-11648191
31 Mar 19132-7738168
31 Dec 18128-4832141
31 Dec 1762-863482

Quality Earnings: 22UA is currently unprofitable.

Growing Profit Margin: 22UA is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 22UA is unprofitable, but has reduced losses over the past 5 years at a rate of 22.7% per year.

Accelerating Growth: Unable to compare 22UA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 22UA is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-18.6%).


Return on Equity

High ROE: 22UA has a negative Return on Equity (-2.64%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies